Idiopathic Pulmonary Fibrosis
📧 Sign up to get email alerts when something new happens for Idiopathic Pulmonary Fibrosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-05Clinical Trial Results: Study of ARO-MMP7 Inhalation Solution in Healthy Participants and Participants With Idiopathic Pulmonary Fibrosis [Phase 1, Phase 2]
Phase 1/2 study of ARO-MMP7 inhalation solution in healthy participants and idiopathic pulmonary fibrosis patients has completed with result…
-
CLINICAL_TRIALS trial_result · 2026-08-05Clinical Trial Results: Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis [Phase 2]
Phase 2 randomized, double-blind trial of Bexotegrast (PLN-74809) for idiopathic pulmonary fibrosis has terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2026-06-26Clinical Trial Results: Cough Reduction in IPF With Nalbuphine ER [Phase 2]
Phase 2 trial results evaluating nalbuphine ER for cough reduction in idiopathic pulmonary fibrosis have been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: A Phase 2 Study of CAL101 in Patients With Idiopathic Pulmonary Fibrosis [Phase 2]
Phase 2 study update for CAL101 in idiopathic pulmonary fibrosis (IPF) is listed as active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis [Phase 2]
A Phase 2 clinical trial to evaluate LTI-03 for idiopathic pulmonary fibrosis is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: Phase ll Study of HEC585 in Patients With IPF [Phase 2]
Phase 2 clinical trial update for HEC585 in idiopathic pulmonary fibrosis; the study is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: Real-life-persistence to Antifibrotic Treatments
A completed real-world study from Boehringer Ingelheim examining how patients with idiopathic pulmonary fibrosis persist with antifibrotic t…
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: Study of Oral Epigallocatechin-3-gallate (EGCG) in IPF Patients [Phase 1]
A Phase 1 study evaluating oral Epigallocatechin-3-gallate (EGCG) in patients with Idiopathic Pulmonary Fibrosis has been completed.
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: Collagen-targeted Positron Emission Tomography (PET) Imaging for Assessment of EGCG Effect [Phase 1]
Phase 1 trial using collagen-targeted PET imaging to assess the effect of epigallocatechin gallate (EGCG) in idiopathic pulmonary fibrosis; …
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Evaluating the Efficacy and Safety of of HSK44459 in People With Idiopathic Pulmonary Fibrosis [Phase 2]
A Phase 2 clinical trial evaluating the efficacy and safety of HSK44459 for idiopathic pulmonary fibrosis has completed.
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: Safety and Efficacy of Nebulized 3D-cultured Human Placental Mesenchymal Stem Cell-derived Extracellular Vesicles (hPMSC-EVs) for Idiopathic Pulmonary Fibrosis [Phase 1]
A Phase 1 clinical trial update evaluating the safety and potential efficacy of nebulized extracellular vesicles derived from 3D-cultured hu…
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: Dyspnea and Idiopathic Pulmonary Fibrosis
A clinical trial investigating dyspnea in idiopathic pulmonary fibrosis has completed.
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis [Phase 3]
A Phase 3 trial evaluating inhaled treprostinil for idiopathic pulmonary fibrosis and interstitial lung disease has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease [Phase 3]
This is a Phase 3 extension study of inhaled treprostinil for fibrotic lung diseases, sponsored by United Therapeutics, with enrollment by i…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: A PhaseⅠ Study of HW252001 in Healthy Subjects [Phase 1]
Phase I trial update for HW252001 in healthy subjects, with idiopathic pulmonary fibrosis listed as a condition and recruitment not yet star…
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis [Phase 3]
A Phase 3 study to evaluate the efficacy, safety, and tolerability of BMS-986278 in participants with Idiopathic Pulmonary Fibrosis. The tri…
-
CLINICAL_TRIALS trial_result · 2026-03-20Clinical Trial Update: Prospective Treatment Efficacy in IPF Using Genotype for Nac Selection (PRECISIONS) Trial [Phase 3]
Phase 3 PRECISIONS trial in idiopathic pulmonary fibrosis has completed, evaluating genotype-guided selection of N-acetylcysteine therapy.
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: A Clinical Study to Evaluate the Efficacy and Safety of REGEND001 Cell Therapy on Idiopathic Pulmonary Fibrosis (IPF) [Phase 2]
Phase 2 clinical study evaluating REGEND001 cell therapy for idiopathic pulmonary fibrosis has completed, assessing efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of GSK3915393 in Participants With Idiopathic Pulmonary Fibrosis (IPF) [Phase 2]
A Phase 2 trial evaluating GSK3915393 for idiopathic pulmonary fibrosis was terminated, indicating the study did not continue to completion.
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: A Adaptive Design Clinical Trial to Evaluate the Efficacy and Safety of TDI01 Suspension in the Treatment of Idiopathic Pulmonary Fibrosis (IPF) [Phase 3]
An adaptive-design Phase 3 trial is evaluating the efficacy and safety of TDI01 suspension in idiopathic pulmonary fibrosis. The study is cu…
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: Effect of CPAP on Abnormal Gastroesophageal Reflux and Lung Inflammation in IPF [NA]
Clinical trial evaluating whether CPAP affects abnormal gastroesophageal reflux and lung inflammation in idiopathic pulmonary fibrosis; the …
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF) [Phase 2]
An update on a Phase 2 clinical trial evaluating oral Ifetroban for idiopathic pulmonary fibrosis (IPF), which is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-03Clinical Trial Update: An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL) [Phase 2]
A Phase 2 extension study for subjects who received Avalyn's inhaled antifibrotic agent (SAIL) is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-02Clinical Trial Update: Application of Personalized Palliative Care in Patients With Newly Diagnosed Idiopathic Pulmonary Fibrosis
A completed clinical trial examining the use of personalized palliative care for patients newly diagnosed with idiopathic pulmonary fibrosis…
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: Autoantibody Reduction for Acute Exacerbations of Idiopathic Pulmonary Fibrosis [Phase 2]
A Phase 2 trial evaluating autoantibody reduction in acute exacerbations of idiopathic pulmonary fibrosis has completed with results posted.